Medifast Revenue, Profits - MED Quarterly Income Statement

Add to My Stocks
$90.95 $0.95 (1.06%) MED stock closing price Mar 20, 2018 (Closing)

MED stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the Medifast stock price. The income statement is a summary of the revenue or sales, expenses and profitability - shown as Net Income, or lack of it. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the MED stock is bound to reflect the impact of the QOQ growth of 1.95%. The Medifast profit and loss statement for 2017 Q3 shows a net profit of $6.69M. Profits for last year was $7.58M. Apart from this an investor should also check Medifast assets and Medifast free cash flow.

View and download details of revenue and profits for Medifast for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q3
Medifast Revenues or Net Sales
Cost Of Goods Sold (COGS)19.02M18.11M17.73M15.4M16.41M17.91M19.15M16.1M16.77M
Medifast Gross Profit
Research & Development Expense---------
Selling General & Admin Expense47.95M46.3M44.28M40.47M43.21M48.2M46.92M39.7M41.18M
Income Before Depreciation Depletion Amortization10.22M11.31M8.6M6.62M8.95M5.02M6.26M5.54M7.97M
Depreciation Depletion Amortization---------
Non Operating Income---------
Interest Expense---------
Medifast Pretax Income
Provision for Income Taxes3.68M3.86M2.56M2.56M2.94M1.69M2.09M2.05M2.7M
Investment Gains Losses---------
Other Income---------
Income Before Extraordinaries & Disc Operations6.69M7.58M6.15M4.11M6.07M3.4M4.26M3.9M5.4M
Extraordinary Items & Discontinued Operations--------0.04M-
Medifast Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS12.1M12.06M12.01M12M11.85M11.88M11.92M11.9M12.02M
Average Shares used to compute Basic EPS11.93M11.93M11.9M11.85M11.85M11.81M11.86M11.77M11.92M
Income Before Nonrecurring Items6.69M7.58M6.15M4.11M6.07M7.46M5.04M3.9M5.4M
Income from Nonrecurring Items------4.06M-0.78M--
Medifast Earnings Per Share Basic Net
Medifast Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items0.550.630.510.340.510.630.420.330.45
Preferred Dividends Acc Pd---------
Dividends Common3.82--------
Dividend Per Share Common0.320.320.320.320.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Medifast stock analysis involves checking at least a few of the important things like:

  • Topline: A growing topline, as seen from the Medifast revenue chart, as is the case with Medifast indicates a growing business. One needs to compare the QoQ topline or sales growth of MED stock with its peers like GNCGY stock and DMND stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $6.69M for MED stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called the profit and loss statement. Apart from the MED income statement, one can check the Medifast historical stock prices to check how the price has moved with time.

Medifast Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
PS Ratio (price sales ratio)
Operating Margin
Net Profit Margin
Dividend Yield